Weiss Multi-Strategy Advisers’s Abeona Therapeutics ABEO Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-400	Closed	-$74K	–	487
2019 Q1	$74K	Hold	400	–	–	﹤0.01%	493
2018 Q4	$71K	Sell	400 -403	-50%	-$87.9K	﹤0.01%	430
2018 Q3	$257K	Buy	+803	New	+$285K	0.01%	485
2017 Q4	–	Sell	-600	Closed	-$256K	–	545
2017 Q3	$256K	Buy	600 +200	+50%	+$53.7K	0.01%	457
2017 Q2	$64K	Buy	+400	New	+$54.6K	﹤0.01%	504
2015 Q4	–	Sell	-1,000	Closed	-$101K	–	380
2015 Q3	$101K	Hold	1,000	–	–	﹤0.01%	378
2015 Q2	$127K	Buy	+1,000	New	+$150K	0.01%	427

Other funds holding ABEO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Weiss Multi-Strategy Advisers's ABEO Position: Q2 2019 in Review

Weiss Multi-Strategy Advisers sold out of Abeona Therapeutics (ABEO) in Q2 2019, closing a stake of 400 shares — an estimated $74K sold.

Weiss Multi-Strategy Advisers first reported a position in ABEO in Q2 2015 and held it in 7 quarters. The position peaked at $257K in Q3 2018. 98 funds tracked by Wall St. Rank hold ABEO as of Q2 2019.

Weiss Multi-Strategy Advisers reported no remaining Abeona Therapeutics position as of Q2 2019 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 400 Abeona Therapeutics shares in Q2 2019, an estimated $74K.
Weiss Multi-Strategy Advisers first reported a position in Abeona Therapeutics in Q2 2015 and held it in 7 quarters.
Weiss Multi-Strategy Advisers's Abeona Therapeutics position peaked at $257K in Q3 2018.
98 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2019.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.